Olfr347 Inhibitors function through various mechanisms to decrease the activity of this specific olfactory receptor. Certain inhibitors operate by blocking the epithelial sodium channels or ion channels that are essential for the initiation and propagation of the receptor's signaling; this action prevents the membrane depolarization or the transduction mechanism that would normally result from Olfr347 activation. Other compounds interfere with intracellular processes such as protein transport and trafficking, which are crucial for the proper cell surface expression and function of Olfr347. Inhibition of the exchange of protein ADP-ribosylation factor, for example, can disrupt the normal trafficking of the receptor to the neuronal cell membrane, thereby reducing its functional presence and activity.
Additionally, some inhibitors target the modulation of neuronal excitability and intracellular calcium levels, which are indirectly tied to Olfr347 function. The use of local anesthetics that block voltage-gated sodium channels can reduce the excitability of neurons expressing Olfr347, leading to a dampened response. Moreover, antagonism of other receptor types and modulation of ryanodine receptors that control calcium release from intracellular stores can influence the cellular environment and downstream signaling pathways necessary for Olfr347 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Blocks epithelial sodium channels in olfactory sensory neurons, potentially reducing the membrane depolarization necessary for Olfr347 activation. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Inhibits certain ionotropic receptors and could interfere with downstream signaling of Olfr347 by modulating intracellular calcium levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of protein ADP-ribosylation factor, which might affect the trafficking and surface expression of Olfr347. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Can bind to and block ion channels, potentially affecting the transduction mechanism of Olfr347. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Known to block ion channels and could indirectly affect the signal transduction of Olfr347. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Blocks voltage-gated sodium channels, potentially reducing the excitability of neurons expressing Olfr347. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Vanilloid receptor antagonist that might alter the sensory neuron responses, indirectly affecting Olfr347 activity. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulates ryanodine receptors involved in calcium release from intracellular stores, potentially impacting Olfr347 signaling. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to alter the function of various receptors and channels, which may lead to decreased activity of Olfr347. | ||||||